The Impact of Smoke Exposure on the Clinical Phenotype of Alpha-1 Antitrypsin Deficiency in Ireland: Exploiting a National Registry to Understand a Rare Disease

References

• Laurell CB, Eriksson S. The electrophoretic alpha1 globulin pattern of serum in alpha1 antitrypsin deficiency. Scand J Clin Lab Invest 1963; 15:132–140.
   Google Scholar
• Luisetti M, Seersholm N. Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency. Thorax 2004; 59(2):164–169.
   PubMed Web of Science ®Google Scholar
• Stoller JK, Sandhaus RA, Turino G, et al. Delay in diagnosis of alpha1-antitrypsin deficiency: a continuing problem. Chest 2005; 128(4):1989–1994.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Resp Crit Care Med 2003; pp. 818–900.
   PubMed Web of Science ®Google Scholar
• Carroll TP, O’Connor CA, Floyd O, et al. The prevalence of alpha-1 antitrypsin deficiency in Ireland. Respir Res 2011; 12:91.
   PubMed Web of Science ®Google Scholar
• Luisetti M, Massi G, Massobrio M, et al. A national program for detection of alpha 1-antitrypsin deficiency in Italy. Gruppo I.D.A. Respir Med 1999; 93(3):169–172.
   PubMed Web of Science ®Google Scholar
• Luisetti M, Miravitlles M, Stockley RA. Alpha1-antitrypsin deficiency: a report from the 2nd meeting of the Alpha One International Registry, Rapallo (Genoa, Italy), 2001. Eur Respir J 2002; 20(4):1050–1056.
   PubMedGoogle Scholar
• Stoller JK, Brantly M, Fleming LE, et al. Formation and current results of a patient-organized registry for alpha(1)-antitrypsin deficiency. Chest 2000; 118(3):843–848.
   PubMed Web of Science ®Google Scholar
• FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993; 122(1):1–9.
   PubMed Web of Science ®Google Scholar
• Ferrarotti I, Carroll TP, Ottaviani S, et al. Identification and characterisation of eight novel SERPINA1 null mutations. Orphanet J Rare Dis 2014; 9(1):172.
   PubMed Web of Science ®Google Scholar
• Silverman EK, Miletich JP, Pierce JA, et al. Alpha-1-antitrypsin deficiency. High prevalence in the St. Louis area determined by direct population screening. Am Rev Respir Dis 1989; 1 40(4):961–966.
   Google Scholar
• de Serres FJ, Blanco I, Fernández-Bustillo E. Genetic epidemiology of alpha-1 antitrypsin deficiency in North America and Australia/New Zealand: Australia, Canada, New Zealand and the United States of America. Clin Genet. 2003 Nov;64(5):382–97.
   PubMed Web of Science ®Google Scholar
• Seersholm N, Kok-Jensen A, Dirksen A. Survival of patients with severe alpha 1-antitrypsin deficiency with special reference to non-index cases. Thorax 1994; 49(7):695–698.
   PubMed Web of Science ®Google Scholar
• Piras B, Ferrarotti I, Lara B, et al. Clinical phenotypes of Italian and Spanish patients with α1-antitrypsin deficiency. Eur Respir J 2013; 42(1):54–64.
   PubMed Web of Science ®Google Scholar
• Molloy K, Hersh CP, Morris VB, et al. Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes. Am J Resp Crit Care Med 2014; 189(4):419–427.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standardization of Spirometry, 1994 Update. Am J Resp Crit Care Med 1995; 1107–1136.
   PubMed Web of Science ®Google Scholar
• Bhalla M, Turcios N, Aponte V, et al. Cystic fibrosis: Scoring system with thin-section CT. Radiology 1991; 179(3): 783–788.
   PubMed Web of Science ®Google Scholar
• McMahon MA, O’Mahony MJ, O’Neill SJ, et al. Alpha-1 antitrypsin deficiency and computed tomography findings. J Comput Assist Tomogr 2005; 29(4):549.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Hurd SS, Agustí AG, et al. Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD Executive Summary. Am J Resp Crit Care Med 2013; 187(4):347–65.
   PubMed Web of Science ®Google Scholar
• Dirksen A, Piitulainen E, Parr DG, et al. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency. Eur Respir J 2009; 33(6):1345–1353.
   PubMed Web of Science ®Google Scholar
• Piitulainen E, Tornling G, Eriksson S. Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PiZZ). Thorax 1997; 52(3):244–248.
   PubMed Web of Science ®Google Scholar
• Cuvelier A, Muir JF, Hellot MF, et al. Distribution of alpha(1)-antitrypsin alleles in patients with bronchiectasis. Chest 2000; 117(2):415–419.
   PubMed Web of Science ®Google Scholar
• Parr DG, Guest PG, Reynolds JH, et al. Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency. Am J Resp Crit Care Med 2007; 176(12):1215–21.
   PubMed Web of Science ®Google Scholar
• McElvaney NG. Smoking ban—made in Ireland, for home use and for export. N Engl J Med 2004; 350(22):2231–2233.
   PubMed Web of Science ®Google Scholar
• Mayer AS, Stoller JK, Vedal S, et al. Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency. Int J Chron Obstruct Pulmon Dis 2006;v1(4):485–492.
   Google Scholar
• Kabir Z, Manning PJ, Holohan J, et al. Second-hand smoke exposure in cars and respiratory health effects in children. Eur Respir J 2009; 34(3):629–633.
   PubMed Web of Science ®Google Scholar
• Turino GM, Barker AF, Brantly ML, et al. Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group. Am J Resp Crit Care Med 1996; 154(6 Pt 1):1718–1725.
   PubMed Web of Science ®Google Scholar
• Ferrarotti I, Baccheschi J, Zorzetto M, et al. Prevalence and phenotype of subjects carrying rare variants in the Italian registry for alpha1-antitrypsin deficiency. J Med Genet 2005; 42(3):282–287.
   PubMed Web of Science ®Google Scholar